LMR Partners’s Pfizer PFE Stock Holding History

LMR Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-100,000	Closed	-$2.49M	–	1770
2025 Q4	$2.49M	Buy	+100,000	New	+$2.52M	﹤0.01%	755
2025 Q1	–	Sell	-112,900	Closed	-$3M	–	1580
2024 Q4	$3M	Sell	112,900 -273,900	-71%	-$7.43M	0.03%	501
2024 Q3	$11.2M	Buy	386,800 +275,000	+246%	+$8.02M	0.09%	201
2024 Q2	$3.13M	Buy	+111,800	New	+$3.08M	0.03%	435
2024 Q1	–	Sell	-475,000	Closed	-$13.7M	–	1273
2023 Q4	$13.7M	Buy	475,000 +196,100	+70%	+$5.93M	0.16%	158
2023 Q3	$9.25M	Buy	278,900 +178,900	+179%	+$6.33M	0.1%	196
2023 Q2	$3.67M	Buy	+100,000	New	+$3.89M	0.04%	284

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

LMR Partners's PFE Position: Q1 2026 in Review

LMR Partners reduced its Pfizer (PFE) stake by 92% in Q1 2026, selling an estimated $12.4M and leaving 39,989 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #960.

LMR Partners first reported a position in PFE in Q4 2015 and has held it in 17 quarters since. The position peaked at $16.9M in Q4 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

LMR Partners held 39,989 shares of Pfizer worth $1.12M as of Q1 2026.
LMR Partners sold 466,562 Pfizer shares in Q1 2026, an estimated $12.4M.
Pfizer made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #960 holding.
LMR Partners first reported a position in Pfizer in Q4 2015 and has held it in 17 quarters since.
LMR Partners's Pfizer position peaked at $16.9M in Q4 2024.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.